Relief for dry eye sufferers

A spray for people with dry eye syndrome has been added to the list of subsidised medications under the Pharmaceutical Benefits Scheme (PBS).

From 1 August the cost of tearsagain will be significantly reduced through the Commonwealth scheme.

As many as one in four people suffer from dry eye syndrome and the likelihood of developing it increases with age. However, until now the cost of the spray has been prohibitive for many pensioners.

The condition causes ongoing discomfort as a result of insufficient lubrication in the eye.

Symptoms include sore, scratchy and itchy eyes along with a gritty sensation, which only worsens with wind and pollen.

The manufacturers of tearsagain say it has been clinically proven to address tear evaporation, the most significant cause of dry eye syndrome.

An unusual feature of the product is that it is sprayed onto the closed eyelid, not directly onto the eye.

The spray can be used with some contact lenses and it has a shelf-life of three years after being opened.

With its new PBS listing, the cost of tearsagain will cost $35 for 2 bottles and valid concession card holders will be able to purchase the spray for $5.30 a bottle.

The tearsagain spray is now available under PBS at pharmacies throughout Australia. For more information, visit www.biorevive.com or call 1300 79 09 78.